We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.
- Authors
Kulke, Matthew H; Tempero, Margaret A; Niedzwiecki, Donna; Hollis, Donna R; Kindler, Hedy L; Cusnir, Michael; Enzinger, Peter C; Gorsch, Stefan M; Goldberg, Richard M; Mayer, Robert J
- Abstract
The relative value of gemcitabine-based combination chemotherapy therapy and prolonged infusions of gemcitabine in patients with advanced pancreatic cancer remains controversial. We explored the efficacy and toxicity of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in a multi-institutional, randomized, phase II study.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 33, p5506
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2009.22.1309